Biotech funding: conversion into tools and CRO orders

perspective

Biotech funding: conversion into tools and CRO orders

active thesis

status monitoring priority medium thesis tickers 5 scan-mentioned tickers 160 events 37 latest

Improving biotech funding will reach tools and CRO revenue through net new orders and project activity, rather than remaining confined to issuance and stock-market enthusiasm.

Watch for: ESCALATION (→ high): a hot biotech IPO prices well + XBI breaks its downtrend + CRO book-to-bill (IQV/MEDP/ICLR/CRL next prints) turns up — funding cycle confirmed turning; rotate into the LAGGARD expressions before they catch up. RATIFICATION GATE: rotation is real once TMO/DHR/MEDP put in positive 3m + RSI > 60 TOGETHER (mega-cap money joining the mid-cap front-run, vs current fast-money front-run). DE-ESCALATION (→ monitoring/low): IPO window stays shut / fresh biotech funding scare → CROs+tools roll back over (mid-cap melt-up was a head-fake). L1 INVALIDATION: AI-bio platforms (RXRX/TEM/DNA) failing to show commercial ROI kills the platform leg regardless of the cycle. Catalyst-verify BR...

cycle18d agoas of
paradigm track record untested — no scored verdicts · low confidence · n=0 cycle

The thesis basket — the 5 tickers this perspective actually tracks. Everything else it has touched is folded below.

TMO $658.02 +8.6% 30d in trend DHR $219.81 +7.3% 30d in trend MEDP $612.05 +4.4% 30d in trend IQV $259.88 +1.1% 30d in trend RGEN $173.88 +5.3% 30d coming into play
Seen alongside in scans (43 shown of 155) — symbols that appear with this perspective, not the thesis basket
AAL $12.76 -1.4% 30d coming into play AAPL $336.64 +6.8% 30d coming into play ABCL $12.55 +13.6% 30d coming into play ABSI $10.16 +17.5% 30d coming into play ABVX $88.15 -26.2% 30d retreating ACHC $29.25 +3.8% 30d coming into play AGIO $31.81 -8.1% 30d coming into play ALAB $342.21 +13.9% 30d coming into play ALMR $25.27 -12.7% 30d too-young AMAT $507.03 +8.1% 30d coming into play AMD $608.10 +16.7% 30d in trend AMKR $49.12 -4.3% 30d retreating AMZN $262.43 +4.0% 30d coming into play ARKG $51.30 +10.8% 30d in trend ARQQ $17.23 -20.4% 30d coming into play ASHR $32.38 -4.9% 30d coming into play ASML $1,780.34 +2.9% 30d coming into play ASX $46.43 +12.7% 30d in trend ATKR $94.84 +0.7% 30d in trend AVAX-USD $10.19 +30.8% 30d in trend AVGO $361.54 -0.8% 30d coming into play AVTR $15.67 +5.3% 30d in trend AXTI $68.46 -0.7% 30d coming into play BABA $111.37 +1.8% 30d retreating BE $280.50 +4.2% 30d coming into play BEAM $25.70 +2.1% 30d retreating BRBR $8.55 -9.3% 30d retreating BRUN $13.18 -24.1% 30d retreating BUG $50.08 +22.5% 30d in trend BWET $998.30 +71.1% 30d in trend CDNA $63.67 +27.3% 30d in trend CEG $298.07 +1.4% 30d coming into play CERT $9.13 +19.7% 30d coming into play CLSK $10.50 -20.9% 30d retreating COHU $68.19 +20.3% 30d in trend COP $134.10 -1.8% 30d in trend CRDO $216.55 +29.0% 30d coming into play CRL $301.79 +8.4% 30d in trend CROX $114.98 +3.5% 30d coming into play CRWD $275.04 +32.4% 30d in trend CVX $211.98 -0.9% 30d in trend
Show all 155 ticker links
$AAL$AAPL$ABCL$ABSI$ABVX$ACHC$AGIO$ALAB$ALMR$AMAT$AMD$AMKR$AMZN$ARKG$ARQQ$ASHR$ASML$ASX$ATAI$ATKR$AVAX-USD$AVGO$AVTR$AXTI$BABA$BE$BEAM$BRBR$BRUN$BUG$BWET$CDNA$CEG$CERT$CLSK$COHU$COP$CRDO$CRL$CRNX$CROX$CRWD$CVX$DAL$DD$DELL$DIA$DK$DOT-USD$DPZ$DRAM$DUK$ENTG$EQNR$ERO$FORM$FTNT$FTRE$FXI$GE$GENB$GLD$GLW$GOOGL$GRAL$HACK$HAL$HIMS$HPE$HQ$IBB$ICHR$ILMN$IONQ$IOVA$IWM$JETS$JNJ$KLAC$KLIC$KOD$KWEB$KYMR$LABU$LAD$LEU$LLY$LRCX$LULU$MAN$MARA$MKSI$MRNA$MRVL$MSFT$MSTR$MTUM$MU$MXL$NAUT$NKE$NVDA$OIH$OKTA$OSCR$P$PACB$PANW$PLTR$PYPL$QQQ$QSI$RARE$RIOT$RSP$RXRX$SBUX$SDGR$SEI$SLB$SLV$SMTC$SNDK$SOXL$SOXS$SPCQ$SPY$SSPC$STX$TER$TLT$TSLA$TWST$TXG$UNH$USO$UUP$VG$VIAV$VIXY$VKTX$VPG$VRTX$VST$VTI$VTV$WDC$XBI$XE$XLC$XLE$XLI$XLK$XOM$ZS
no live data (2) — unresolved, delisted, or non-US symbols
$ATAI$CRNX

Desk commentary

Authored analysis and challenge notes tied to Biotech funding: conversion into tools and CRO orders.

2

The Thread

The thesis as it unfolds — by source type (the symbol grid above is the current state).

Recent Shifts

12

Signals

2

Research

5

Captures

2

Calendar & Lifecycle

14